Corpus Intelligence IC Memo — LEES SUMMIT MEDICAL CENTER 2026-04-26 09:38 UTC
IC Memo — LEES SUMMIT MEDICAL CENTER
Investment Committee Memorandum | MO | 80 beds | Grade C | EBITDA uplift $10.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

LEES SUMMIT MEDICAL CENTER

CCN 260190 | JACKSON, MO | 80 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

LEES SUMMIT MEDICAL CENTER is a 80-bed suburban community hospital in JACKSON, MO with $146.7M in net patient revenue and a 13.6% operating margin. The hospital serves a payer mix of 29.3% Medicare, 5.5% Medicaid, and 65.2% commercial.

Thesis: Turnaround. Our ML models identify $10.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 13.6% to 20.9% (+736bps).

Net Revenue HCRIS$146.7M
Current EBITDA COMPUTED$19.9M
Operating Margin COMPUTED13.6%
Occupancy HCRIS85.0%
Revenue / Bed COMPUTED$1.8M
Net-to-Gross HCRIS14.9%
Distress Probability ML38.0%

2. Market Context & Competitive Position

138
MO Hospitals
-6.2%
State Median Margin
52
Comparable Hospitals

MO has 138 Medicare-certified hospitals with a median operating margin of -6.2%. The target's margin of 13.6% places it above the state median. Among 52 size-comparable peers (40-160 beds), the median margin is -6.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (40-160), prioritizing same-state peers. 52 hospitals in the comp set.

HospitalStateBedsRevenueMargin
LEES SUMMIT MEDICAL CENTER (Target)MO80$146.7M13.6%
LAKE REGIONAL HEALTH SYSTEMMO105$226.8M-2.7%
HANNIBAL REGIONAL HOSPITALMO86$226.2M-6.8%
CAPITAL REGION MEDICAL CENTERMO100$224.0M-17.7%
BARNES JEWISH WEST COUNTY HOSPMO68$221.1M4.9%
COX MEDICAL CENTER BRANSONMO144$217.3M-0.8%
MERCY HOSPITAL - WASHINGTONMO140$202.9M16.4%
SAINT LUKES NORTH HOSPITALMO108$183.6M-6.4%
CITIZENS MEMORIAL HOSPITAL DISMO52$178.3M-19.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $10.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.1M+210bp18mo
Cost to Collect4.5%2.5%$2.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.9M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.8M+122bp9mo
Clean Claim Rate88.0%96.0%$94K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.1M
Cost to Collect
$2.9M
Denial Rate Reduction
$2.9M
A/R Days Reduction
$1.8M
Clean Claim Rate
$94K
Total EBITDA Uplift$10.8M
Current EBITDA$19.9M
+ RCM Uplift+$10.8M
Pro Forma EBITDA$30.7M
Current Margin13.6%
Pro Forma Margin20.9%
WC Released (1x)$5.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$30.6M$239.2M7.82x50.9%
Base (11x exit)10.0x11.0x$30.6M$273.1M8.92x54.9%
Bull Case9.0x11.0x$27.5M$318.6M11.57x63.2%
Bull (12x exit)9.0x12.0x$27.5M$355.7M12.91x66.8%
Bear Case11.0x10.0x$33.7M$175.3M5.21x39.1%
Bear (11x exit)11.0x11.0x$33.7M$203.7M6.05x43.3%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 52 hospitals with 40-160 beds
  • Same-state prioritization (n=53)
  • Comp margins: P25=-16.7% / P50=-6.6% / P75=8.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.